VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 5 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,722,000 | -87.5% | 2,630 | +186.2% | 0.10% | -91.8% |
| Q4 2017 | $13,772,000 | -68.4% | 919 | -67.9% | 1.25% | -55.9% |
| Q3 2017 | $43,559,000 | -25.8% | 2,865 | -37.1% | 2.85% | -25.9% |
| Q2 2017 | $58,675,000 | +289.9% | 4,553 | +230.9% | 3.84% | +372.8% |
| Q1 2017 | $15,047,000 | +90.9% | 1,376 | +28.6% | 0.81% | +76.9% |
| Q4 2016 | $7,883,000 | -53.8% | 1,070 | -45.3% | 0.46% | -28.2% |
| Q3 2016 | $17,050,000 | +225.4% | 1,955 | +221.0% | 0.64% | +134.1% |
| Q2 2016 | $5,239,000 | +19.8% | 609 | +10.7% | 0.27% | +24.7% |
| Q1 2016 | $4,372,000 | +1.9% | 550 | +61.3% | 0.22% | -7.2% |
| Q4 2015 | $4,291,000 | +20.8% | 341 | 0.0% | 0.24% | +61.6% |
| Q3 2015 | $3,551,000 | +113.0% | 341 | +152.6% | 0.15% | +139.3% |
| Q2 2015 | $1,667,000 | -39.6% | 135 | -42.3% | 0.06% | -47.0% |
| Q1 2015 | $2,760,000 | -94.0% | 234 | -94.0% | 0.12% | -92.1% |
| Q4 2014 | $46,106,000 | -81.9% | 3,881 | -82.9% | 1.46% | -85.1% |
| Q3 2014 | $254,596,000 | -9.9% | 22,669 | -24.0% | 9.78% | -19.3% |
| Q2 2014 | $282,487,000 | +66.4% | 29,836 | +24.3% | 12.11% | +27.3% |
| Q1 2014 | $169,728,000 | -14.3% | 24,000 | -10.0% | 9.52% | -24.7% |
| Q4 2013 | $198,091,000 | +5.0% | 26,661 | +7.1% | 12.63% | +3.0% |
| Q3 2013 | $188,716,000 | +2.4% | 24,890 | +7.9% | 12.26% | -0.3% |
| Q2 2013 | $184,220,000 | – | 23,065 | – | 12.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 86,000 | $14,617,000 | 0.12% |
| SIMPLEX TRADING, LLC | 572 | $9,721,000 | 0.04% |
| JPMORGAN CHASE & CO | 66,600 | $11,319,000 | 0.00% |
| Allianz Asset Management GmbH | 3,900 | $663,000 | 0.00% |